Sabiedrība ar ierobežotu atbildību "Baltic Pharma"Active
Key figures
Ratios
2025Balance sheet structure
Summary of financial statements2011–2025
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||||||||||
| Total current assets | 11 390 | 13 358 | 21 490 | 31 910 | 37 947 | 26 843 | 18 758 | 19 203 | 15 675 | 17 130 | 16 715 | 5893 | 6236 | 611 | 811 |
| Total non-current assets | 0 | 3496 | 1728 | 526 | 319 | 397 | 243 | 89 | 0 | 0 | 0 | 0 | 320 | 288 | 288 |
| Total assets | 11 390 | 16 854 | 23 218 | 32 436 | 38 266 | 27 240 | 19 001 | 19 292 | 15 675 | 17 130 | 16 715 | 5893 | 6556 | 899 | 1099 |
| Balance sheet — liabilities and equity | |||||||||||||||
| Current liabilities | 0 | 1476 | 6876 | 14 410 | 25 604 | 20 888 | 22 027 | 22 254 | 25 024 | 11 755 | 14 590 | 6194 | 5817 | 740 | 1405 |
| Non-current liabilities | 9390 | 26 399 | 29 510 | 44 969 | 45 296 | 47 094 | 34 620 | 42 288 | 34 228 | 31 744 | 29 105 | 28 664 | 28 364 | 0 | 0 |
| Total liabilities | 9390 | 27 875 | 36 386 | 59 379 | 70 900 | 67 982 | 56 647 | 64 542 | 59 252 | 43 499 | 43 695 | 34 858 | 34 181 | 740 | 1405 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | 0 | -13 021 | -2147 | -8207 | -5691 | -8107 | 3096 | -7604 | 1673 | 17 208 | -611 | -1985 | 1339 | 26 247 | -1256 |
| Total equity | 2000 | -11 021 | -13 168 | -26 943 | -32 634 | -40 742 | -37 646 | -45 250 | -43 577 | -26 369 | -26 980 | -28 965 | -27 625 | -1380 | -2637 |
| Income statement | |||||||||||||||
| Sales revenue | 0 | 8257 | 6706 | 9887 | 13 454 | 9767 | 31 859 | 19 740 | 7854 | 20 087 | 2962 | 1697 | 4612 | 4575 | 1251 |
| Operating profit | 0 | -13 021 | -2147 | -8199 | -5552 | -8087 | 3293 | -7603 | 1676 | 17 209 | -561 | -1935 | 1391 | 26 300 | -1206 |
| EBITDA | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit before income tax | 0 | -13 021 | -2147 | -8207 | -5691 | -8107 | 3220 | -7604 | 1673 | 17 208 | -561 | -1935 | 1389 | 26 297 | -1206 |
| Profit for the reporting year | 0 | -13 021 | -2147 | -8207 | -5691 | -8107 | 3096 | -7604 | 1673 | 17 208 | -611 | -1985 | 1339 | 26 247 | -1256 |
| Labour costs | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | |||||||||||||||
| Employees | 0 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| Calculated dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
Summary: Sabiedrība ar ierobežotu atbildību "Baltic Pharma"
Overview
Sabiedrība ar ierobežotu atbildību "Baltic Pharma" (reg. no. 40103351440) is a limited liability company. The company was registered in 2010 and has been in the register for 15 years. Registered address: Rīga, Bruņinieku iela 25.
Financial results
Revenue in 2025 was 1251 €, down 72,7% on the previous year (4575 €). 2025 ended with a loss of 1256 €. The company was profitable in 5 of the 15 published years. In 2025 the company had 1 employees (2 a year earlier). Revenue per employee was 1251 €.
Management and owners
The board has 2 members. According to the register, the company has 3 owners. The largest stake (39,9%) is held by a private individual.
Points to note
Equity was negative at the end of 2025 (-2637 €).
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.